
WaiveDx is revolutionizing precision health by integrating AI-driven diagnostics and therapeutics across clinical, legal, and wellness sectors. Their proprietary AI engine, Nymara, automates clinical interpretation, compliance, and predictive modeling, transforming genetic and biomarker data into personalized recommendations. The company offers a diversified model including SaaS platforms for healthcare providers, direct-to-consumer wellness kits, legal applications utilizing genetic evidence, and federal program support. Key products include NeuDefense for legal cases, WellGenx and Velisce for personalized wellness, and PredictIQ™ and Synapta™ for clinical decision support. WaiveDx emphasizes speed, accuracy, interoperability, and compliance, leveraging blockchain technology for secure data management and seamlessly integrating with existing healthcare systems.

WaiveDx is revolutionizing precision health by integrating AI-driven diagnostics and therapeutics across clinical, legal, and wellness sectors. Their proprietary AI engine, Nymara, automates clinical interpretation, compliance, and predictive modeling, transforming genetic and biomarker data into personalized recommendations. The company offers a diversified model including SaaS platforms for healthcare providers, direct-to-consumer wellness kits, legal applications utilizing genetic evidence, and federal program support. Key products include NeuDefense for legal cases, WellGenx and Velisce for personalized wellness, and PredictIQ™ and Synapta™ for clinical decision support. WaiveDx emphasizes speed, accuracy, interoperability, and compliance, leveraging blockchain technology for secure data management and seamlessly integrating with existing healthcare systems.